Skin Cancer Market Growing Rapidly Huge Growth by 2031- Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc.

Skin Cancer Market is expected to grow at a CAGR 8% during the forecast period (2024-2031).

Skin cancer, the most common cancer type, is primarily caused by solar and artificial ultraviolet (UV) radiation, responsible for about 90% of cases. UV radiation leads to mutations and disruptions in tumor suppressor genes, promoting skin malignancies. The Skin Cancer Market analysis provides a detailed outlook, covering market size, trends, and growth by treatment type and end user. It offers forecasts until 2029 for key regions, including the U.S., Europe, Brazil, China, and India.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/skin-cancer-market

Market Trends:

The rising diagnosis of skin cancer is expected to drive market growth. From 1994 to 2020, nonmelanoma skin cancer diagnoses in the U.S. increased by 77%, with sun exposure to UV radiation being a major risk factor. Approximately 9,500 people in the U.S. are diagnosed with skin cancer daily, with an estimated 196,060 new melanoma cases in 2021. Skin cancer is more common in non-Hispanic whites and is often diagnosed later in people of color, affecting areas less exposed to the sun. The increased diagnosis rates, especially among different demographics, are expected to boost market growth.

Segment Covered in the Skin Cancer Market:
By Treatment Type: Chemotherapy, Surgery, Non-Invasive Treatments, and Others
By End User: Hospital and Clinics, Cancer Research Institutes and Others

Regional Analysis:
The global skin cancer market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

The global skin cancer market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The skin cancer market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Major Key Players
• Amgen, Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Sun Pharmaceutical Industries Ltd.
• Abbott Laboratories.
• Sanofi SA
• Novartis AG
• Qiagen NV
• Pfizer Inc.

Product Portfolio:
IMLYGIC (talimogene laherparepvec) is a prescription medication for treating melanoma that is either on the skin or in the lymph glands.

Related Reports
Stomach Cancer Treatment Market: https://www.datamintelligence.com/research-report/stomach-cancer-treatment-market

Ovarian Cancer Market: https://www.datamintelligence.com/research-report/ovarian-cancer-market

Mantle Cell Lymphoma Market: https://www.datamintelligence.com/research-report/mantle-cell-lymphoma-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/skin-cancer-market

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.